Infection prevention & Control Market - Forecast(2020 - 2025)

Report Code: HCR 0022 Report Format: PDF + Excel (Delivery in 48 Hrs)
Infection Prevention and Control Market size is anticipated to reach $201.71 billion by 2025, growing at a CAGR of 3.7% during the forecast period 2020-2025. With Infections and Infectious Diseases taking an extraordinary turn in all countries an incorporated methodology is required to decrease the burden thereby uniting treatment of patients and health promotions. Trends towards a fundamental understanding of the study of disease transmission; risk factors that expand persistent powerlessness to disease; and the practices, techniques and medications that may bring about contamination have clearly benefited Infection Prevention and Control market. 

Key Takeaways
  • North America region is anticipated to grasp 44.8% share during the forecast period.
  • The concern for cleanliness and hygienic of all workers in keeping the environment neat; prevents the workers as well as the patients from various Health Associated Infections.
  • Control from various types of cross-infections in hospitals and clinics also there has been a growth of Personal Protective Equipment’s market globally.

Infection Type- Segment Analysis
In 2019, Bacterial Infections segment dominated the Infection prevention and control market. The advancements in technologies, increasing of consumer wealth due to population growth coupled with growing needs of the people towards the healthcare settings will drive the market in this region. The prevalent burden of health care-associated infection is increasing significantly higher in low- and middle-income than in high-income countries, and mostly to the patients admitted to intensive care units and in neonates with weaker immune system.

Anti-Microbial Drug Type- Segment Analysis
In 2019, anti-bacterial drug segment dominated the Infection prevention and control market. The different classes of antibacterial drugs that are currently being in the market all have diverse performance profiles, but they share a common characteristic under some useful set of condition of being lethal to micro bacteria. Regardless of numerous genuine drawbacks, the different formulations that keep up their business sector development rates is evidence of the interest for antimicrobial products.

Product & Service Equipment - Segment Analysis
The Personal protective equipment segment of Infection protection and control market is anticipated to hold major share of IP&C Market followed by Disinfectants and Sterilization. With the growth in prevention and control concerns of various Health Associated Infections, Personal Protective Equipment’s accounted for 31% of the Global IP&C Market shares. To control various types of cross-infections in hospitals and clinics also there has been a growth of Personal Protective Equipment’s market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.

By End-User - Segment Analysis
At the end-user, Manufacturing Units of Infection prevention and control market will continue to dominate the IP&C Market during the forecast period. The concern for cleanliness and hygienic of all workers helps in keeping the environment neat and prevent the workers as well as the patients from various Health Associated Infections.

By Geography - Segment Analysis
North America region is anticipated to grasp 44.8% share during the forecast period. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America and Europe. With development, rising economies, changing lifestyle and emerging microbial threat in APAC region will act as major key factors for enhancement of the global IP&C Market.    

Drivers – Infection Prevention and Control Market

  • Increase In Incidence Of Hospital Acquired Infections (HAIS)
Hospital acquired infections (HAI) are infections that patients come across as a result of medical services intervention to treat other conditions. The increasing rate of Hospital Acquired Infection has led to the increase in the demand of the infection prevention and control products such as syringes, gloves, disinfectants, disposable needles and so on. The advent of various infectious disease testing kits, proper means of sanitation method has also provided a wide contribution towards the increasing sales of the product in the global market.
 
Challenges – Infection Prevention and Control Market

  • Low Level Of Vaccination Among Healthcare Workers
Healthcare workers play an important role in advocating seasonal influenza vaccination to their patients. Most health care workers accept that they are healthy and in this manner will get no profit from vaccination or that the danger of unfriendly occasions after vaccination exceeds the profits. On the other hand, they are basically uninformed of the proposals for yearly flu inoculation. Vaccination for health care workers can possibly profit health care experts, their patients, and their families by lessening the transmission of the microorganisms in the health care setting.

Infection Prevention and Control Industry Outlook
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Infection Prevention and Control market. In 2019, Infection Prevention and Control market share is fragmented by the top ten players present in the market. Infection Prevention and Control market top 10 companies are Abbott, Ansell Ltd., Astra Zeneca, Medtronic, Johnson& Johnson, Kimberly-Clark, Merck& Co, Pfizer Inc., Roche, Siemens and others.

Acquisitions/Product Launches
  • In October 2017, Abbott’s worldwide diagnostics business, sales growth over the last three years reflected the acquisition of Alere.
  • On December 2017, BD completed the acquisition of Bard, a global medical technology company in the fields of vascular, urology, oncology and surgical specialty products.

1. Infection prevention & Control Market Overview
    1.1.  Definitions and Scope
2. Infection prevention & Control Market  - Executive Summary
    2.1. Market Revenue, Market Size and Key Trends by Company
    2.2. Key trends by Products and Service Equipment
    2.3. Key trends by Geography
3.  Infection prevention & Control Market Landscape
    3.1. Market Share Analysis
    3.2. Comparative Analysis 
        3.2.1. Product Benchmarking
        3.2.2. End User profiling
        3.2.3. Patent Analysis
        3.2.4. Key Companies Financials Analysis
4. Infection prevention & Control Market Forces
    4.1. Market Drivers
    4.2. Market Constraints & Challenges
    4.3. Market Opportunities
    4.4. Porters five force model
        4.4.1. Bargaining power of suppliers
        4.4.2. Bargaining powers of customers
        4.4.3. Threat of new entrants
        4.4.4. Rivalry among existing players
        4.4.5. Threat of substitutes 
5. Infection prevention & Control Market - By Strategic Analysis 
    5.1. Value Chain Analysis
    5.2. Pricing Analysis
    5.3. Market Life Cycle Analysis
    5.4. Suppliers and Distributors
6. Infection prevention & Control Market – By Infection Type
    6.1. Microbial infections
        6.1.1. Bacterial Infections
            6.1.1.1. Mycobacterium Tuberculosis
        6.1.2. Clostridium Difficile Infections
            6.1.2.1. Escherichia Coli Infections
            6.1.2.2. Helicobacter Pylori
            6.1.2.3. Salmonella
            6.1.2.4. Others
        6.1.3. Viral Infections
            6.1.3.1. Ebola Virus
            6.1.3.2. Human Immunodeficiency Virus (HIV)
            6.1.3.3. Herpes Simplex Virus
            6.1.3.4. Yellow Fever
            6.1.3.5. Dengue Viruses
            6.1.3.6. Others
        6.1.4. Fungal Infections
            6.1.4.1. Cryptococcus Gatti
            6.1.4.2. Aspergillis
            6.1.4.3. PCP: Pneumocystis Pneumonia
            6.1.4.4. Dermatophytes
            6.1.4.5. Others
        6.1.5. Exserohilum
    6.2. Healthcare Associated Infections
        6.2.1. Hospital Acquired Infection
            6.2.1.1. Central line associated bloodstream infection (CLABSI)
            6.2.1.2. Catheter associated Urinary Tract infection
            6.2.1.3. Surgical site infection 
            6.2.1.4. Ventilator associated Pneumonia (VAP) infection
        6.2.2. Community acquired infection
            6.2.2.1. Methicillin resistant Staphylococcus Aureus (MRSA) infection
            6.2.2.2. Community Acquired Pneumonia (CAP)
7. Infection prevention & Control Market- By Antimicrobial Drugs
    7.1. Anti-Bacterial Drugs
    7.2. Anti-Viral Drugs
    7.3. Anti-Fungal Drugs
    7.4. Vaccines
8. Infection prevention & Control Market- By Products & Services Equipment 
    8.1. Personal Protective Equipment
        8.1.1. Gloves
        8.1.2. Surgical Masks & Respirators
        8.1.3. Surgical Drapes & Gown
        8.1.4. Surgical Foot covers 
        8.1.5. Medical safety Glasses
        8.1.6. Others
    8.2. Disinfectants
        8.2.1. Hand sanitizers
        8.2.2. Disinfectants wipes
        8.2.3. Surface Disinfectants
        8.2.4. Instrument Disinfectants
        8.2.5. Surgical Disinfectants
        8.2.6. Environmental Disinfectants
        8.2.7. Others
    8.3. Sterilization
        8.3.1. Medical Device Sterilization Equipment
            8.3.1.1. Wet/Stream Sterilization (Autoclave)
                    8.3.1.1.1. Vertical Autoclave
                    8.3.1.1.2. Horizontal Autoclave
                    8.3.1.1.3. Portable Autoclave
            8.3.1.2. Dry Heat Sterilization
            8.3.1.3. Low Temperature Sterilization
                    8.3.1.3.1. In-House Steam Sterilization
                    8.3.1.3.2. Ethylene Oxide (EO) Sterilization
                    8.3.1.3.3. Gamma and e-Beam Sterilization
    8.4. Autoclave
        8.4.1. Vertical Autoclave
        8.4.2. Horizontal Autoclave
        8.4.3. Portable Autoclave
9. Infection prevention & Control Market- By End Use Industry 
    9.1. By Equipment Usage
        9.1.1. Hospitals & Clinics
        9.1.2. Medical Laboratories
        9.1.3. Manufacturing Units
            9.1.3.1. Pharmaceuticals
            9.1.3.2. Medical Devices
            9.1.3.3. Food & Beverages Industry
    9.2. By Drug Usage
        9.2.1. Individuals & Patients
        9.2.2. Nursing & Senior care Centers
10. Infection Prevention & Control Market -  By Geography
    10.1. North America 
        10.1.1. U.S. 
        10.1.2. Canada 
        10.1.3. Mexico    
    10.2. Europe 
        10.2.1. U.K 
        10.2.2. Germany 
        10.2.3. Italy 
        10.2.4. France
        10.2.5. Netherlands
        10.2.6. Rest of Europe
    10.3. APAC
        10.3.1. China 
        10.3.2. Australia & New Zealand 
        10.3.3. India
        10.3.4. Japan
        10.3.5. Rest of APAC
    10.4. Rest of World
        10.4.1. Africa
        10.4.2. Middle East
        10.4.3. South America
11. Infection Prevention & Control Market- Entropy
12. Company Profiles (Overview, Financials, Developments, Product Portfolio)
    12.1. Company 1
    12.2. Company 2
    12.3. Company 3
    12.4. Company 4
    12.5. Company 5
    12.6. Company 6
    12.7. Company 7
    12.8. Company 8
    12.9. Company 9
    12.10. Company 10
"*Financials would be provided on a best efforts basis for private companies"
List of Tables:
    
Table 1: Infection prevention & Control Market Overview 2019-2024
Table 2: Infection prevention & Control Market Leader Analysis 2018-2019 (US$)
Table 3: Infection prevention & Control Market Product Analysis 2018-2019 (US$)
Table 4: Infection prevention & Control Market End User Analysis 2018-2019 (US$)
Table 5: Infection prevention & Control Market Patent Analysis 2013-2018* (US$)
Table 6: Infection prevention & Control Market Financial Analysis 2018-2019 (US$)
Table 7: Infection prevention & Control Market Driver Analysis 2018-2019 (US$)
Table 8: Infection prevention & Control Market Challenges Analysis 2018-2019 (US$)
Table 9: Infection prevention & Control Market Constraint Analysis 2018-2019 (US$)
Table 10: Infection prevention & Control Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Infection prevention & Control Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Infection prevention & Control Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Infection prevention & Control Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Infection prevention & Control Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Infection prevention & Control Market Value Chain Analysis 2018-2019 (US$)
Table 16: Infection prevention & Control Market Pricing Analysis 2019-2024 (US$)
Table 17: Infection prevention & Control Market Opportunities Analysis 2019-2024 (US$)
Table 18: Infection prevention & Control Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Infection prevention & Control Market Supplier Analysis 2018-2019 (US$)
Table 20: Infection prevention & Control Market Distributor Analysis 2018-2019 (US$)
Table 21: Infection prevention & Control Market Trend Analysis 2018-2019 (US$)
Table 22: Infection prevention & Control Market Size 2018 (US$)
Table 23: Infection prevention & Control Market Forecast Analysis 2019-2024 (US$)
Table 24: Infection prevention & Control Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Infection prevention & Control Market, Revenue & Volume, By Infections, 2019-2024 ($)
Table 26: Infection prevention & Control Market By Infections, Revenue & Volume, By Microbial infections, 2019-2024 ($)
Table 27: Infection prevention & Control Market By Infections, Revenue & Volume, By Healthcare Associated Infections, 2019-2024 ($)
Table 28: Infection prevention & Control Market, Revenue & Volume, By Antimicrobial drugs, 2019-2024 ($)
Table 29: Infection prevention & Control Market By Antimicrobial drugs, Revenue & Volume, By Anti-bacterial Drug, 2019-2024 ($)
Table 30: Infection prevention & Control Market By Antimicrobial drugs, Revenue & Volume, By Anti-Viral Drug, 2019-2024 ($)
Table 31: Infection prevention & Control Market By Antimicrobial drugs, Revenue & Volume, By Anti-fungal Drug, 2019-2024 ($)
Table 32: Infection prevention & Control Market By Antimicrobial drugs, Revenue & Volume, By Vaccine, 2019-2024 ($)
Table 33: Infection prevention & Control Market, Revenue & Volume, By Accessories and Equipment, 2019-2024 ($)
Table 34: Infection prevention & Control Market By Accessories and Equipment, Revenue & Volume, By Personal Protective Equipment, 2019-2024 ($)
Table 35: Infection prevention & Control Market By Accessories and Equipment, Revenue & Volume, By Disinfectants, 2019-2024 ($)
Table 36: Infection prevention & Control Market By Accessories and Equipment, Revenue & Volume, By Sterilization, 2019-2024 ($)
Table 37: Infection prevention & Control Market, Revenue & Volume, By End User Industry, 2019-2024 ($)
Table 38: Infection prevention & Control Market By End User Industry, Revenue & Volume, By Equipment Usage, 2019-2024 ($)
Table 39: Infection prevention & Control Market By End User Industry, Revenue & Volume, By Drug Usage, 2019-2024 ($)
Table 40: North America Infection prevention & Control Market, Revenue & Volume, By Infections, 2019-2024 ($)
Table 41: North America Infection prevention & Control Market, Revenue & Volume, By Antimicrobial drugs, 2019-2024 ($)
Table 42: North America Infection prevention & Control Market, Revenue & Volume, By Accessories and Equipment, 2019-2024 ($)
Table 43: North America Infection prevention & Control Market, Revenue & Volume, By End User Industry, 2019-2024 ($)
Table 44: South america Infection prevention & Control Market, Revenue & Volume, By Infections, 2019-2024 ($)
Table 45: South america Infection prevention & Control Market, Revenue & Volume, By Antimicrobial drugs, 2019-2024 ($)
Table 46: South america Infection prevention & Control Market, Revenue & Volume, By Accessories and Equipment, 2019-2024 ($)
Table 47: South america Infection prevention & Control Market, Revenue & Volume, By End User Industry, 2019-2024 ($)
Table 48: Europe Infection prevention & Control Market, Revenue & Volume, By Infections, 2019-2024 ($)
Table 49: Europe Infection prevention & Control Market, Revenue & Volume, By Antimicrobial drugs, 2019-2024 ($)
Table 50: Europe Infection prevention & Control Market, Revenue & Volume, By Accessories and Equipment, 2019-2024 ($)
Table 51: Europe Infection prevention & Control Market, Revenue & Volume, By End User Industry, 2019-2024 ($)
Table 52: APAC Infection prevention & Control Market, Revenue & Volume, By Infections, 2019-2024 ($)
Table 53: APAC Infection prevention & Control Market, Revenue & Volume, By Antimicrobial drugs, 2019-2024 ($)
Table 54: APAC Infection prevention & Control Market, Revenue & Volume, By Accessories and Equipment, 2019-2024 ($)
Table 55: APAC Infection prevention & Control Market, Revenue & Volume, By End User Industry, 2019-2024 ($)
Table 56: Middle East & Africa Infection prevention & Control Market, Revenue & Volume, By Infections, 2019-2024 ($)
Table 57: Middle East & Africa Infection prevention & Control Market, Revenue & Volume, By Antimicrobial drugs, 2019-2024 ($)
Table 58: Middle East & Africa Infection prevention & Control Market, Revenue & Volume, By Accessories and Equipment, 2019-2024 ($)
Table 59: Middle East & Africa Infection prevention & Control Market, Revenue & Volume, By End User Industry, 2019-2024 ($)
Table 60: Russia Infection prevention & Control Market, Revenue & Volume, By Infections, 2019-2024 ($)
Table 61: Russia Infection prevention & Control Market, Revenue & Volume, By Antimicrobial drugs, 2019-2024 ($)
Table 62: Russia Infection prevention & Control Market, Revenue & Volume, By Accessories and Equipment, 2019-2024 ($)
Table 63: Russia Infection prevention & Control Market, Revenue & Volume, By End User Industry, 2019-2024 ($)
Table 64: Israel Infection prevention & Control Market, Revenue & Volume, By Infections, 2019-2024 ($)
Table 65: Israel Infection prevention & Control Market, Revenue & Volume, By Antimicrobial drugs, 2019-2024 ($)
Table 66: Israel Infection prevention & Control Market, Revenue & Volume, By Accessories and Equipment, 2019-2024 ($)
Table 67: Israel Infection prevention & Control Market, Revenue & Volume, By End User Industry, 2019-2024 ($)
Table 68: Top Companies 2018 (US$) Infection prevention & Control Market, Revenue & Volume
Table 69: Product Launch 2018-2019 Infection prevention & Control Market, Revenue & Volume
Table 70: Mergers & Acquistions 2018-2019 Infection prevention & Control Market, Revenue & Volume
    

List of Figures:
    
Figure 1: Overview of Infection prevention & Control Market 2019-2024
Figure 2: Market Share Analysis for Infection prevention & Control Market 2018 (US$)
Figure 3: Product Comparison in Infection prevention & Control Market 2018-2019 (US$)
Figure 4: End User Profile for Infection prevention & Control Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Infection prevention & Control Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Infection prevention & Control Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Infection prevention & Control Market 2018-2019
Figure 8: Ecosystem Analysis in Infection prevention & Control Market 2018
Figure 9: Average Selling Price in Infection prevention & Control Market 2019-2024
Figure 10: Top Opportunites in Infection prevention & Control Market 2018-2019
Figure 11: Market Life Cycle Analysis in Infection prevention & Control Market
Figure 12: GlobalBy Infections Infection prevention & Control Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Antimicrobial drugs Infection prevention & Control Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy Accessories and Equipment Infection prevention & Control Market Revenue, 2019-2024 ($)
Figure 15: GlobalBy End User Industry Infection prevention & Control Market Revenue, 2019-2024 ($)
Figure 16: Global Infection prevention & Control Market - By Geography
Figure 17: Global Infection prevention & Control Market Value & Volume, By Geography, 2019-2024 ($)
Figure 18: Global Infection prevention & Control Market CAGR, By Geography, 2019-2024 (%)
Figure 19: North America Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 20: US Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 21: US GDP and Population, 2018-2019 ($)
Figure 22: US GDP – Composition of 2018, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2018-2019 ($)
Figure 24: Canada Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 25: Canada GDP and Population, 2018-2019 ($)
Figure 26: Canada GDP – Composition of 2018, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 28: Mexico Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 29: Mexico GDP and Population, 2018-2019 ($)
Figure 30: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 32: South America Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 33: Brazil Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 34: Brazil GDP and Population, 2018-2019 ($)
Figure 35: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 37: Venezuela Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 38: Venezuela GDP and Population, 2018-2019 ($)
Figure 39: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 41: Argentina Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 42: Argentina GDP and Population, 2018-2019 ($)
Figure 43: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 45: Ecuador Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 46: Ecuador GDP and Population, 2018-2019 ($)
Figure 47: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 49: Peru Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 50: Peru GDP and Population, 2018-2019 ($)
Figure 51: Peru GDP – Composition of 2018, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 53: Colombia Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 54: Colombia GDP and Population, 2018-2019 ($)
Figure 55: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 57: Costa Rica Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 58: Costa Rica GDP and Population, 2018-2019 ($)
Figure 59: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 61: Europe Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 62: U.K Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 63: U.K GDP and Population, 2018-2019 ($)
Figure 64: U.K GDP – Composition of 2018, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 66: Germany Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 67: Germany GDP and Population, 2018-2019 ($)
Figure 68: Germany GDP – Composition of 2018, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 70: Italy Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 71: Italy GDP and Population, 2018-2019 ($)
Figure 72: Italy GDP – Composition of 2018, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 74: France Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 75: France GDP and Population, 2018-2019 ($)
Figure 76: France GDP – Composition of 2018, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2018-2019 ($)
Figure 78: Netherlands Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 79: Netherlands GDP and Population, 2018-2019 ($)
Figure 80: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 82: Belgium Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 83: Belgium GDP and Population, 2018-2019 ($)
Figure 84: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 86: Spain Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 87: Spain GDP and Population, 2018-2019 ($)
Figure 88: Spain GDP – Composition of 2018, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 90: Denmark Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 91: Denmark GDP and Population, 2018-2019 ($)
Figure 92: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 94: APAC Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 95: China Infection prevention & Control Market Value & Volume, 2019-2024
Figure 96: China GDP and Population, 2018-2019 ($)
Figure 97: China GDP – Composition of 2018, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2018-2019 ($) Infection prevention & Control Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 99: Australia Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 100: Australia GDP and Population, 2018-2019 ($)
Figure 101: Australia GDP – Composition of 2018, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 103: South Korea Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 104: South Korea GDP and Population, 2018-2019 ($)
Figure 105: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 107: India Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 108: India GDP and Population, 2018-2019 ($)
Figure 109: India GDP – Composition of 2018, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2018-2019 ($)
Figure 111: Taiwan Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 112: Taiwan GDP and Population, 2018-2019 ($)
Figure 113: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 115: Malaysia Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 116: Malaysia GDP and Population, 2018-2019 ($)
Figure 117: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 119: Hong Kong Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 120: Hong Kong GDP and Population, 2018-2019 ($)
Figure 121: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 123: Middle East & Africa Infection prevention & Control Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 124: Russia Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 125: Russia GDP and Population, 2018-2019 ($)
Figure 126: Russia GDP – Composition of 2018, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 128: Israel Infection prevention & Control Market Value & Volume, 2019-2024 ($)
Figure 129: Israel GDP and Population, 2018-2019 ($)
Figure 130: Israel GDP – Composition of 2018, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 132: Entropy Share, By Strategies, 2018-2019* (%) Infection prevention & Control Market
Figure 133: Developments, 2018-2019* Infection prevention & Control Market
Figure 134: Company 1 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 1 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 1 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 2 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 2 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 2 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 3 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 3 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 3 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 4 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 4 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 4 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 5 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 5 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 5 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 6 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 6 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 6 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 7 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 7 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 7 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 8 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 8 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 8 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 9 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 9 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 9 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 10 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 10 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 10 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 11 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 11 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 11 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 12 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 12 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 12 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 13 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 13 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 13 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 14 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 14 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 14 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)
Figure 176: Company 15 Infection prevention & Control Market Net Revenue, By Years, 2018-2019* ($)
Figure 177: Company 15 Infection prevention & Control Market Net Revenue Share, By Business segments, 2018 (%)
Figure 178: Company 15 Infection prevention & Control Market Net Sales Share, By Geography, 2018 (%)